Transactions
Abveris acquired by Twist Bioscience
Dec. 2021
Client: Abveris is a premier therapeutic and reagent antibody discovery platform, providing services to leading biotech and pharmaceutical companies
Role: Edgemont Partners acted as exclusive financial advisor to Abveris in its sale to Twist Bioscience
Location: Canton, MA
Sector: Pharmaceutical Services
Lead Banker: David Blume
acquired by
